The polymer biomaterial segment in the global biomaterial market is expected to witness the fastest growth, a CAGR of 19.2% during the forecast period.
The global biomaterial market is growing at a significant rate, due to increasing healthcare expenditure, growing geriatric population and increasing incidence of cardiovascular diseases. The technological advancement in biomaterials, growing demand of implantable devices, and increasing incidence of hip and knee replacements are also driving the growth of the global biomaterial market. However, factors such as strict regulatory requirements for approval of biomaterials and limitations of biomaterials are inhibiting growth of the market globally.
Explore report sample at: https://www.psmarketresearch.com/market-analysis/biomaterials-market/report-sample
Biomaterial is a nonviable material used in medical devices or during interaction with biological systems. It is an essential material used for medical applications to substitute a part or a function of body in reliable, safe, and physiologically acceptable method. It poses properties such as biocompatibility, high corrosion resistance, adequate strength, and biofunctionality. Some of the commonly used biomaterials include cellulose, silicone rubber, collagen, titanium, stainless steel, polyurethanes, poly (methyl methacrylate) and hydrogels. The emergence of innovative biomaterial products and advances in technology has improved biomaterials applications and performance.
Some of the key companies operating in the global biomaterial market include Wright Medical Technology Inc., Corbion N.V., Royal DSM, Zimmer Biomet Holdings Inc., Collagen Matrix Inc., Berkeley Advanced Biomaterials Inc., and Cam Bioceramics BV.
Source: P&S Intelligence